临床和分子表征的患者与catecholaminergic多态心室性心动减速
Silvia G Priori1, Carlo Napolitano, Mirella Memmi
1Molecular Cardiology, IRCCS Fondazione S. Maugeri, University of Pavia, Pavia, Italy. spriori@fsm.it
catecholaminergic多形心室性心力衰竭 (CPVT) 与RyR2基因突变有关. 患有RyR2突变的患者会出现更早的症状,男性面临更高的风险,需要有针对性的评估和治疗.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子心脏病学分子心脏病学
- 遗传性心律失常综合征 遗传性心律失常综合征
背景情况:
- catecholaminergic多形心室性心力衰竭 (CPVT) 是一种与心脏瑞诺丁受体基因 (RyR2) 突变相关的遗传性心律失常症.
- 在CPVT患者中RyR2突变的患病率和RyR2-相关CPVT (RyR2-CPVT) 与非基因型CPVT的独特临床特征仍然不完全理解.
更多相关视频
09:20Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
相关概念视频
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
